Parsons Brian A, Evans Simon, Wright Mark P
Department of Urology, Bristol Royal Infirmary, Bristol, United Kingdom.
Maturitas. 2009 Aug 20;63(4):323-8. doi: 10.1016/j.maturitas.2009.06.005. Epub 2009 Jul 16.
Prostate cancer is the third most common cancer worldwide and an increasing proportion of men are being diagnosed with localised disease. Urinary incontinence is uncommon in healthy men, but may develop as a result of curative treatment for prostate cancer. The optimal therapy remains undefined so the treatment associated morbidity is an important determinant in patient choice. Urinary incontinence may also develop from tumour progression during deferred treatment, sphincter involvement in advanced disease or surgery for symptomatic malignant bladder outlet obstruction. As urinary incontinence is known to have a significant impact on health related quality of life, we have reviewed the literature on incontinence related to prostate cancer and its treatment.
前列腺癌是全球第三大常见癌症，被诊断为局限性疾病的男性比例正在上升。健康男性中尿失禁并不常见，但可能是前列腺癌根治性治疗的结果。最佳治疗方法仍不明确，因此治疗相关的发病率是患者选择的重要决定因素。尿失禁也可能由于延迟治疗期间的肿瘤进展、晚期疾病中括约肌受累或有症状的恶性膀胱出口梗阻手术而发生。由于已知尿失禁会对健康相关生活质量产生重大影响，我们回顾了与前列腺癌及其治疗相关的尿失禁文献。
